Saba Capital Management L.P. 增加了菲尼克斯生物技术收购公司（纳斯达克股票代码：PBAX）的股票头寸

Saba Capital Management L.P. lifted its holdings in Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX – Get Rating) by 7.1% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,212,426 shares of the company's stock after purchasing an additional 80,000 shares during the period. Saba Capital Management L.P. owned about 5.28% of Phoenix Biotech Acquisition worth $12,233,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in PBAX. Glazer Capital LLC bought a new position in shares of Phoenix Biotech Acquisition in the 3rd quarter worth approximately $103,000. OLD Mission Capital LLC bought a new position in shares of Phoenix Biotech Acquisition in the 3rd quarter worth approximately $106,000. Calamos Advisors LLC bought a new position in shares of Phoenix Biotech Acquisition in the 3rd quarter worth approximately $253,000. Verition Fund Management LLC bought a new position in shares of Phoenix Biotech Acquisition in the 3rd quarter worth approximately $264,000. Finally, Sculptor Capital LP bought a new position in shares of Phoenix Biotech Acquisition in the 1st quarter worth approximately $276,000. Institutional investors own 65.93% of the company's stock.

Phoenix Biotech Acquisition Stock Performance

Shares of NASDAQ:PBAX opened at $10.68 on Friday. The firm's 50 day moving average price is $10.50 and its 200-day moving average price is $10.28. Phoenix Biotech Acquisition Corp. has a twelve month low of $9.96 and a twelve month high of $10.68.

About Phoenix Biotech Acquisition

(Get Rating)

Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe.

Featured Stories

• Get a free copy of the StockNews.com research report on Phoenix Biotech Acquisition (PBAX)
• What the SVB Financial Collapse Means for U.S. Banks
• MarketBeat Week in Review – 3/6 – 3/10
• 2 Offshore Drilling Stocks Set to Extract Big Profits
• Three Staples Stocks With Double-Digit Upside Ahead
• Can Investors Trust Consumers to Lift American Outdoor Brands?

Want to see what other hedge funds are holding PBAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX – Get Rating).

Receive News & Ratings for Phoenix Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phoenix Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.